Label Literacy

What a Proprietary Blend Does — and Doesn't — Tell You

Published July 12, 2026 · The Ingredient Brief

A proprietary blend tells you which ingredients are in the bottle and what the blend weighs in total. It does not tell you how much of each one you are getting. Almost everything that matters about a supplement lives in that gap.

What the label is actually required to say

Under US labelling rules, a dietary supplement has to list its ingredients. When those ingredients are combined into a proprietary blend, the manufacturer is permitted to declare the total weight of the blend and list the ingredients inside it in descending order by weight — without disclosing the individual amounts.

So a panel that reads “Proprietary Urinary Support Blend — 480 mg: cranberry extract, bearberry, berberine, Mimosa pudica” is telling you four true things and withholding one important one. The four: those ingredients are present, they sum to 480 mg, cranberry is the largest of the four, and Mimosa pudica is the smallest. The one withheld: the actual milligrams of any single ingredient.

Why the gap matters more than it sounds

Almost every ingredient with real research behind it has a dose attached to that research. A study does not find that “cranberry works.” It finds that a specific preparation, at a specific dose, produced a specific measured outcome. Detach the dose and the citation stops being evidence about the product in your hand.

This creates a structural asymmetry. A manufacturer can lawfully include a researched ingredient at a fraction of the studied dose — enough to name it on the panel, not enough to expect the studied effect — and the label will look identical to one that includes the full dose. The industry term for this is fairy dusting. The proprietary blend is what makes it invisible.

We want to be precise: a proprietary blend is not evidence of fairy dusting. Plenty of formulators use blends for ordinary competitive reasons — they would rather not hand a competitor an exact recipe. The point is narrower and harder to argue with: a blend removes your ability to check.

What you can still infer

A blend is not a total blackout. Three things remain readable:

  • Descending order. Ingredients must be listed heaviest first. If the ingredient the marketing is built around appears last in a nine-item blend, that is informative.
  • The ceiling. No single ingredient can exceed the blend's total weight. If a study used 500 mg of one compound and the entire blend is 480 mg, the studied dose is arithmetically impossible — regardless of what the marketing implies.
  • The count. A 480 mg blend split across nine ingredients averages roughly 53 mg each. Averages hide distribution, but they do bound the plausible range, and long ingredient lists in small blends are worth noticing.

That ceiling check is the single most useful thing on this page, and it takes about thirty seconds: find the studied dose of the headline ingredient, compare it to the total blend weight, and see whether the arithmetic even permits the claim.

What a fully disclosed panel looks like

The alternative is a panel that lists each ingredient with its own amount and its own % Daily Value where one exists. Some manufacturers do this deliberately and say so, because a checkable label is itself a selling point. When you see it, you can do the comparison the research invites: studied dose versus label dose, ingredient by ingredient.

When you don't see it, the honest conclusion is not “this product is bad.” It is “this product is unverifiable on the dimension that decides whether the research applies to it.” Those are different statements, and conflating them is how people end up either dismissing good formulas or trusting bad ones.

The practical rule

When a label shows a proprietary blend, downgrade every ingredient-based claim it makes from demonstrated to plausible. Then decide whether the rest of the offer — the formulator's transparency elsewhere, third-party testing, the return policy — gives you enough to act on. Sometimes it will. But make the decision knowing that the label handed you a shorter ruler than it appeared to.

The short version

  • A blend discloses presence and order, not dose.
  • Research is dose-dependent; without doses, ingredient citations are suggestive, not probative.
  • Do the ceiling check: studied dose vs. total blend weight. If it doesn't fit, the claim can't either.
  • A blend is a reason to lower confidence — not automatic evidence of a bad product.

Sources

  • US Food and Drug Administration — Dietary Supplement Labeling Guide, Chapter IV (Nutrition Labeling) and Chapter VI (Ingredient Labeling).
  • Code of Federal Regulations — 21 CFR 101.36, Nutrition labeling of dietary supplements, including the treatment of proprietary blends.